SIGA Technologies, Inc.

NASDAQ:SIGA

Drug Manufacturers - Specialty & Generic

Healthcare
$2.80 -0.36%

-$0.02 today

Market cap
$201.19M
Beta
0.85
P/E (TTM)
15.2
EPS (TTM)
$0.28
Dividend yield
13.97%
52W Low $4.10High $9.62

Volume 0.37M

Average 0.61M

SIGA Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

SIGA Technologies, Inc.NASDAQ: SIGA

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 71.65M shares rose 0.3% year over year, in line with the -0.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at -0.9% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.3% holds above the trailing-twelve-month pace of -0.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
71.65M+0.1% QoQ
Last fiscal yearDec 2025
71.6M-0.2% YoY
LTMMar 2026
71.65M-0.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.3%——
1 year-0.2%——
3-year CAGR-0.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
71.6M USD
Year-over-year change
-0.2%
4-year CAGR
-1.6%

Weighted Avg Shares (Diluted) vs competitors

How SIGA compares with its peers on the latest reported figures

  • SIGA's LTM Mar 2026 weighted avg shares (diluted) of 71.65M shares is the 7th highest of the 10 companies compared; the peer median is 113.62M shares.
  • Its year-over-year change of -0.0% is the 7th highest of 10, against a peer median of +19.8%.
  • Over three fiscal years its annual growth of -0.9% compares with a peer median of +28.0%.
SIGA Competitors Peer median
Weighted Avg Shares (Diluted) for SIGA and competitors
Company Period LTM YoY 3-year CAGR
SNDLSNDL Inc.LTM Mar 2026261.05M -0.7%+3.9%
ESPREsperion Therapeutics, Inc.LTM Mar 2026232.73M +20.1%+46.3%
CTMXCytomX Therapeutics, Inc.LTM Mar 2026160.38M +90.2%+28.0%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026129.43M -1.4%-0.5%
AQSTAquestive Therapeutics, Inc.LTM Mar 2026113.62M +23.3%+35.8%
OLMAOlema Pharmaceuticals, Inc.LTM Mar 202691.34M +41.8%+29.6%
SIGASIGA Technologies, Inc.LTM Mar 202671.65M -0.0%-0.9%
EBSEmergent BioSolutions Inc.LTM Mar 202654.9M -0.0%+4.2%
DRIODarioHealth Corp.LTM Mar 202649.63M +19.8%+28.1%
RIGLRigel Pharmaceuticals, Inc.LTM Mar 202618.96M +6.3%+3.0%
Peer median (excluding SIGA) 113.62M+19.8%+28.0%

Competitors are the stored peer set for SIGA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue133.67M110.78M139.92M138.72M94.6M
Cost of Revenue16.6M10.43M17.83M31.29M29.7M
Gross Profit117.07M100.34M122.09M107.43M64.87M
Gross Margin87.6%90.6%87.3%77.4%68.6%
Research & Development9.94M22.53M16.43M12.31M6.53M
Selling, General & Admin18.03M35.12M22.04M25.14M3.13M
Operating Expenses27.98M57.64M38.47M37.45M41.17M
Depreciation & Amortization522.37K517.64K538.29K538.42K562.61K
EBITDA89.83M44.65M88.31M76.61M30.96M
EBITDA Margin67.2%40.3%63.1%55.2%32.7%
Operating Income89.09M42.7M83.62M69.98M23.7M
Operating Margin66.7%38.5%59.8%50.4%25.1%
Interest Income00006.68M
Interest Expense00000
Other Income / Expenses218.94K1.43M4.16M6.09M6.7M
Income Before Tax89.31M44.13M87.78M76.07M30.4M
Pre-Tax Margin66.8%39.8%62.7%54.8%32.1%
Income Tax Expense19.86M10.23M19.71M16.86M7.1M
Net Income69.45M33.9M68.07M59.21M23.3M
Net Margin52.0%30.6%48.6%42.7%24.6%
EPS (Basic)0.920.460.950.830.33
EPS (Diluted)0.910.460.950.830.33
Weighted Avg Shares75.32M72.93M71.36M71.25M71.6M
Weighted Avg Shares (Diluted)76.4M73.55M71.68M71.77M71.6M

SIGA Technologies, Inc.

NASDAQ:SIGA

Intrinsic Alpha fair value

Locked

Current Price

$2.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.